MAGGIE CROYLE: Open Payments
NPI 1174294250 · KITTANNING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,603 in 130 payments from 40 companies in 2025. Trend: 2023 $18 · 2024 $2,161 · 2025 $2,603
Food & beverage: $2,503Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 23 | $361 |
| Novartis Pharmaceuticals Corporation | 11 | $233 |
| Janssen Biotech, Inc. | 10 | $187 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $147 |
| Incyte Corporation | 5 | $125 |
| Astellas Pharma US Inc | 2 | $122 |
| AstraZeneca Pharmaceuticals LP | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Geron Corporation | 3 | $79 |
| Lilly USA, LLC | 3 | $73 |
Products named: Enhertu, Nubeqa, ERLEADA, SCEMBLIX, LIBTAYO, INJECTAFER, RYTELO, KISQALI.
Industry payments across PA — which companies pay providers there.
